Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study

Stopped early

Conditions studied: Arrythmia

In brief

Study to evaluate the safety and procedural performance of the KODEX - EPD System when used in the treatment of cardiac arrhythmias. An additional objective is to develop patient specific optimized therapy (PSOT PMCF) via machine learning to improve future treatment of cardiac arrhythmias (PSOT).

Key facts

Study ID
NCT03481413
Run by
EPD Solutions, A Philips Company
People needed
566
Starts
2018-11-30
Expected to finish
2023-03-30
Last updated by the study team
2023-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.